Deficiency of the fifth component of complement in mice with an inherited complement defect.
about
Deficiency in complement C1q improves histological and functional locomotor outcome after spinal cord injuryDBA/2J genetic background exacerbates spontaneous lethal seizures but lessens amyloid deposition in a mouse model of Alzheimer's disease.C5 deficiency in A/J mice is not associated with resistance to the development of secondary amyloidosis.PECAM-independent thioglycollate peritonitis is associated with a locus on murine chromosome 2Localization of the mouse gene releasing sex-limited expression of Slp.Induction of dermal-epidermal separation in mice by passive transfer of antibodies specific to type VII collagen.Resistance to listeriosis in mice that are deficient in the fifth component of complement.Experimental Chagas' disease in complement-deficient mice and guinea pigsGenetic control of susceptibility to Cryptococcus neoformans in mice.A novel role for the fifth component of complement (C5) in cardiac physiology.Quantification of mouse macrophage chemotaxis in vitro: role of C5 for the production of chemotactic activity.Role of complement during experimental Candida infection in mice.Pulmonary response of fifth component of complement-sufficient and -deficient mice to hyperoxia.Influence of internalin A murinisation on host resistance to orally acquired listeriosis in mice.Cytogenetic engineering in vivo: restoration of biologic complement activity to C5-deficient mice by intravenous inoculation of hybrid cells.Characterization of protective T cells in the acquired response to Leishmania donovani in genetically determined cure (H-2b) and noncure (H-2d) mouse strains.Allergens induce enhanced bronchoconstriction and leukotriene production in C5 deficient mice.Hereditary deficiency of the fifth component of complement in man. II. Biological properties of C5-deficient human serumMurine complement reduces infectivity of Plasmodium yoelii to mosquitoesTwo antigens on zygotes and ookinetes of Plasmodium yoelii and Plasmodium berghei that are distinct targets of transmission-blocking immunityCoxsackievirus B-3 myocarditis. Identification of different pathogenic mechanisms in DBA/2 and Balb/c mice.Murine membranous nephropathy: immunization with α3(IV) collagen fragment induces subepithelial immune complexes and FcγR-independent nephrotic syndrome.A simple PCR-based method for the rapid genotyping of inherited fifth complement component (C5)-deficient mice.Mouse cytomegalovirus. Necrosis of infected and morphologically normal submaxillary gland acinar cells during termination of chronic infectionInteractions of the complement system with endotoxic lipopolysaccharide. Generation of a factor chemotactic for polymorphonuclear leukocytes.Binding of soluble immune complexes to human lymphoblastoid cells. I. Characterization of receptors for IgG Fc and complement and description of the binding mechanism.Protection against lethal challenge of BALB/c mice by passive transfer of monoclonal antibodies to five glycoproteins of herpes simplex virus type 2.Serum-mediated leukemia cell destruction in AKR mice.Antigenic modulation of Friend virus erythroleukemic cells in vitro by serum from mice with dormant erythroleukemia.Genetic susceptibility to murine collagen II autoimmune arthritis. Proposed relationship to the IgG2 autoantibody subclass response, complement C5, major histocompatibility complex (MHC) and non-MHC lociBinding of components of the properdin system to cultured human lymphoblastoid cells and B lymphocytesGenetic linkage between serum levels of the third component of complement and the H-2 complexMemory B cell development but not germinal center formation is impaired by in vivo blockade of CD40-CD40 ligand interaction.Transgenic mice overexpressing the complement inhibitor crry as a soluble protein are protected from antibody-induced glomerular injuryRole of Fc fragments in antibody-mediated recovery from ocular and subcutaneous herpes simplex virus infections.In vivo evidence that an intact lytic complement pathway is not essential for successful removal of circulating Borrelia turicatae from mouse blood.Chromosomal locations and gonadal dependence of genes that mediate resistance to ectromelia (mousepox) virus-induced mortality.Comparison of the susceptibilities of C57BL/6 and A/J mouse strains to Streptococcus suis serotype 2 infection.Passive immunization against Cryptococcus neoformans with an isotype-switch family of monoclonal antibodies reactive with cryptococcal polysaccharideAcute joint inflammation in mice after systemic injection of the cell wall, its peptidoglycan, and chemically defined peptidoglycan subunits from various bacteria
P2860
Q24645659-7C6165C5-B070-4342-BD14-8547972F979AQ30412535-3FF2B9A3-4196-4D69-9FE6-1E5D25B5BABEQ33197578-263D721D-E25B-4768-BBB5-4719C0251C42Q33404086-33F1C2B0-3AAA-4770-95CF-D03E40D312CFQ33589484-6764DA77-F148-4240-BA53-D103055D2EE6Q33726907-BAC2B96D-8A8C-4882-A77C-2BD7CC183C6EQ33897596-0A415A39-E752-4828-9BC4-3F6541C138B1Q33902609-BDE74620-6306-4625-8DA3-F17CBC8625B1Q33906527-552AAFA0-4729-4BE4-A5CF-680948A6DDB5Q33988617-74577C6E-7084-4DA1-8A35-F623EADC1374Q34116148-A4EA7A0B-6CF0-42A3-AEA0-79DDA364FBA4Q34168998-01F665FF-CB43-4612-9298-62BCF7F61C2DQ34614450-3C80BB06-DDED-4E79-8260-403FF24F877EQ34687016-0E71AECB-B6E3-45A5-B7CE-42E7941CED09Q34743197-41006F17-B1A1-4D39-B056-A7E303138556Q35102523-02ECFA16-63D9-47F6-AAF5-7C4F3A15DA92Q35129075-08F26D5D-FA66-47DD-A983-E0FE8D9611F7Q35202080-03C3032D-DDAE-4FAC-B3A7-504C120F6202Q35439705-04B221B9-40B3-4201-9E9F-443AE696061AQ35549265-95D98A8F-809D-4929-B3F6-485D40630758Q35835669-DE3FDDEF-C524-4DAA-B578-17C86908AF51Q35851046-B54F4697-BC08-4C9C-9E87-ACC102A398E5Q35991991-D7C5C304-0B95-44CB-8308-EF608D8267D8Q36078364-A8CDCE10-C943-454F-A863-A05CEF1912A0Q36269256-9C6C08D3-E009-4EFE-A294-1F474ACDECDBQ36273333-1B2615A3-7081-4640-BAAB-FF48FF55864DQ36333640-186CF850-9323-4B91-817D-8FC02930F0BEQ36334974-DF6D9D4F-B872-4EC2-80DD-16ECAB33C1DFQ36335718-5BA16F6E-E808-47E7-943B-BDB01CC652A2Q36351401-8DA1B44F-5FE9-4491-B3D5-AFF9ED4DB0B1Q36359022-FEFDCB72-3136-4FB1-9812-62A556E9370FQ36360234-3A06A112-3C4F-4427-8B26-59970BD2E917Q36363287-72DAC52D-2825-4559-A107-0F4A0EF94AC6Q36401591-6414DED8-AE11-44FB-8868-C38E4A077784Q36423892-9ADBE347-BB54-4A42-8C8A-8A90EB86C289Q36455493-AC947149-4ED6-4DDB-9D82-92983F170D02Q36684200-EC3C859F-1497-4C28-A274-5493476D657DQ36845138-23970F21-E27E-455E-999A-6731C04EDA14Q36984524-E2064C76-9ACA-4F10-A9D5-CDAE1D82D489Q37052570-A841D070-9E57-4401-948A-E414D675C979
P2860
Deficiency of the fifth component of complement in mice with an inherited complement defect.
description
1967 nî lūn-bûn
@nan
1967年の論文
@ja
1967年学术文章
@wuu
1967年学术文章
@zh-cn
1967年学术文章
@zh-hans
1967年学术文章
@zh-my
1967年学术文章
@zh-sg
1967年學術文章
@yue
1967年學術文章
@zh
1967年學術文章
@zh-hant
name
Deficiency of the fifth compon ...... n inherited complement defect.
@ast
Deficiency of the fifth compon ...... n inherited complement defect.
@en
type
label
Deficiency of the fifth compon ...... n inherited complement defect.
@ast
Deficiency of the fifth compon ...... n inherited complement defect.
@en
prefLabel
Deficiency of the fifth compon ...... n inherited complement defect.
@ast
Deficiency of the fifth compon ...... n inherited complement defect.
@en
P2860
P356
P1476
Deficiency of the fifth compon ...... n inherited complement defect.
@en
P2093
Müller-Eberhard HJ
Nilsson UR
P2860
P356
10.1084/JEM.125.1.1
P407
P577
1967-01-01T00:00:00Z